Publications by authors named "Selda Samakoglu"

Claim this Profile
E
Efficacy and safety results from CheckMate 140, a phase 2 study of nivolumab for relapsed/refractory follicular lymphoma.
Philippe Armand, Ann Janssens, Giuseppe Gritti, John Radford, John Timmerman, Selda Samakoglu

Blood· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid Tumors.
David Hong, Drew Rasco, Michael Veeder, Jason J Luke, Jason Chandler, Selda Samakoglu

Oncology· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab for Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Patients Ineligible for or Having Failed Autologous Transplantation: A Single-Arm, Phase II Study.
Stephen M Ansell, Monique C Minnema, Peter Johnson, John M Timmerman, Philippe Armand, Selda Samakoglu

J Clin Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical rationale for combining an EGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC.
Selda Samakoglu, Dhanvanthri S Deevi, Huiling Li, Su Wang, Mary Murphy

Cancer Genomics Proteomics· July 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimating preclinical efficacy targets utilizing cetuximab efficacy in KRAS mutant and wild-type colorectal cancer models.
Marie Prewett, Rajiv Bassi, Keren Paz, Michael Amatulli, Dhanvanthri Deevi, Selda Samakoglu

Anticancer Res· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pleiotropic stromal effects of vascular endothelial growth factor receptor 2 antibody therapy in renal cell carcinoma models.
Inga J Duignan, Erik Corcoran, Anthony Pennello, Mary Jane Plym, Michael Amatulli, Selda Samakoglu

Neoplasia· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Progress toward the genetic treatment of the beta-thalassemias.
Michel Sadelain, Leszek Lisowski, Selda Samakoglu, Stefano Rivella, Chad May

Ann N Y Acad Sci· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genetic strategy to treat sickle cell anemia by coregulating globin transgene expression and RNA interference.
Selda Samakoglu, Leszek Lisowski, Tulin Budak-Alpdogan, Yelena Usachenko, Santina Acuto

Nat Biotechnol· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
Michel Sadelain, Stefano Rivella, Leszek Lisowski, Selda Samakoglu, Isabelle Rivière

Best Pract Res Clin Haematol· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanisms leading to sustained reversion of beta-thalassemia in mice by doxycycline-controlled Epo delivery from muscles.
Selda Samakoglu, Delphine Bohl, Jean Michel Heard

Mol Ther· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis